The Korean Hereditary Breast Cancer Study: Review and Future Perspectives

被引:24
作者
Kang, Eunyoung [1 ]
Kim, Sung-Won [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Surg, Songnam 463707, South Korea
关键词
BRCA1; genes; BRCA2; Breast neoplasms; Hereditary neoplastic syndromes; RISK-REDUCING SURGERY; OVARIAN-CANCER; MUTATION CARRIERS; PRACTICE PATTERNS; BRCA1; SUSCEPTIBILITY; SURVIVAL; OOPHORECTOMY; ASSOCIATION; BRCA1/BRCA2;
D O I
10.4048/jbc.2013.16.3.245
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Most studies related to BRCA mutations have been performed in Western populations, and only a few small studies have been conducted in Korean populations. In 2007, the Korean Hereditary Breast Cancer (KOHBRA) Study was established to obtain evidence for the accurate risk assessment and management of hereditary breast and ovarian cancer (HBOC) in Korea. Between May 2007 and May 2010, the first phase of the KOHBRA Study was performed to estimate the prevalence of BRCA1/2 mutations among patients and their families at risk for HBOC. Between June 2010 and May 2013, the second phase of the KOHBRA Study was performed to identify the clinical characteristics and prognostic indicators of BRCA-related breast cancer and environmental and genetic modifiers of BRCA mutations and to develop a Korean BRCA risk calculator and nationwide genetic counseling network for HBOC. Herein, we review the results of the KOHBRA Study and describe the future perspectives of the study.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 45 条
[1]  
[Anonymous], GEN FAM HIGH RISK AS
[2]   The BOADICEA model of genetic susceptibility to breast and ovarian cancer [J].
Antoniou, AC ;
Pharoah, PPD ;
Smith, P ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1580-1590
[3]  
Berliner Janice L, 2007, J Genet Couns, V16, P241, DOI 10.1007/s10897-007-9090-7
[4]   Meta-analysis of BRCA1 and BRCA2 penetrance [J].
Chen, Sining ;
Parmigiani, Giovanni .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1329-1333
[5]   Incidental Detection of Ductal Carcinoma In Situ of the Breast from Bilateral Prophylactic Mastectomy of Asymptomatic BRCA2 Mutation Carrier: A Case Report [J].
Choi, Min-Young ;
Lee, Jeong Eon ;
Kim, Sung-Won ;
Lee, Se Kyung ;
Hur, Sung Mo ;
Kim, Sangmin ;
Koo, Min Young ;
Bae, Soo Youn ;
Choe, Jun-Ho ;
Kim, Jung-Han ;
Kim, Jee Soo ;
Nam, Seok Jin ;
Yang, Jung-Hyun .
JOURNAL OF BREAST CANCER, 2010, 13 (03) :311-317
[6]  
Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO
[7]  
2-Z
[8]   Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality [J].
Domchek, Susan M. ;
Friebel, Tara M. ;
Singer, Christian F. ;
Evans, D. Gareth ;
Lynch, Henry T. ;
Isaacs, Claudine ;
Garber, Judy E. ;
Neuhausen, Susan L. ;
Matloff, Ellen ;
Eeles, Rosalind ;
Pichert, Gabriella ;
Van T'veer, Laura ;
Tung, Nadine ;
Weitzel, Jeffrey N. ;
Couch, Fergus J. ;
Rubinstein, Wendy S. ;
Ganz, Patricia A. ;
Daly, Mary B. ;
Olopade, Olufunmilayo I. ;
Tomlinson, Gail ;
Schildkraut, Joellen ;
Blum, Joanne L. ;
Rebbeck, Timothy R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (09) :967-975
[9]   Survival and recurrence after breast cancer in BRCA1/2 mutation carriers [J].
El-Tamer, M ;
Russo, D ;
Troxel, A ;
Bernardino, LP ;
Mazziotta, R ;
Estabrook, A ;
Ditkoff, BA ;
Schnabel, F ;
Mansukhani, M .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) :157-164
[10]   Update on the Manchester scoring system for BRCA1 and BRCA2 testing -: art. no. e39 [J].
Evans, DGR ;
Lalloo, F ;
Wallace, A ;
Rahman, N .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (07)